Medical Specialists can now More Accurately Test for Cervical Cancer

Johns Hopkins’ scientists have reported they have developed a urine test that predicts cervical cancer that is highly accurate compared to other tests based on genetic markers derived directly from cervical tissue.

Not only does this particular urine test detect DNA changes from precancerous cells, it also detects the human DNA alterations from Human Papillomavirus (HPV), a sexually transmitted disease directly linked to cervical cancer.

Read more in the original article from the ASCO post


PrecisionPlan for Oncology Professionals

Build Actionable, Patient-Specific Cancer Treatment Plans

Integrate or embed the Viviphi™ Artificial Intelligence Clinical Brain into your health system or cancer center EMR to make optimal, personalized, and patient-centered decisions.

Our codified clinical knowledge allows for expert-to-expert consultations and actionable patient-specific pathways built in seconds. 

PrecisionPlan™ is a comprehensive and continuum-based platform that outlines in detail the most appropriate clinical guidance in chemotherapy, immunotherapy, genomic-guided targeted therapy, anti-hormonal therapy, radiation therapy, surgery, supportive care, palliative care and follow up/survivorship that is unique to each patient.